| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Human germ cell tumours comprise a heterogeneous group of neoplasms. In the testis, three entities are distinguished, the teratomas-yolk sac tumours of the infantile testis, the seminomas and nonseminomas of adolescents and adults, and the spermatocytic seminomas. Studies on epidemiology, histology, clinical behaviour, and chromosomal constitution of these tumours support the concept of distinct entities derived from germ cells but each with a different pathogenesis. Either the teratomas of the infantile testis show no chromosomal aberrations, or display a pattern of over- and under-representation of (parts of) chromosomes as detected in the yolk sac tumours of the infantile testis. In contrast, the seminomas and nonseminomas reveal a consistent pattern of losses and gains, that is, chromosomes 11, 13 and 18, and 7, 8 and X, respectively, that is different from that found in the infantile testis teratomas and yolk sac tumours. The most consistent structural chromosomal abnormality is an isochromosome 12p. Tumours lacking i(12p) have other structural abnormalities of 12p, among them amplification of 12p11.2-p12.1. The pathogenetically relevant genes on 12p11.2-p12.1 are probably on a fragment of about 1.7 mb. Gain of 12p sequences may be related to invasive growth. Gain of chromosome 9 is the only consistent chromosomal anomaly of spermatocytic seminomas. Infantile teratomas and spermatocytic seminomas are benign tumours. Infantile yolk sac tumour is a malignant germ cell tumour. Seminomas and nonseminomas are malignant, and the most common cancer in young Caucasian males. The cure rate of seminomas and non-seminomas with radio- and chemotherapy is over 90%, which is higher than that of any other solid cancer in adults. In addition, the precursor lesions of these tumours can be treated readily, justifying efforts to develop means for early diagnosis. Finally, the pathogenetic relationship between seminomas and nonseminomas, and the available animal models for the three groups of testicular germ cell tumours are discussed.
This article has been cited by other articles:
 |
|
 |
|
  L. Cheng, S. Zhang, G. T. MacLennan, C. K. Poulos, M.-T. Sung, S. D. Beck, and R. S. Foster Interphase Fluorescence In situ Hybridization Analysis of Chromosome 12p Abnormalities Is Useful for Distinguishing Epidermoid Cysts of the Testis from Pure Mature Teratoma. Clin. Cancer Res., October 1, 2006; 12(19): 5668 - 5672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Veltman, L. A. Vreede, J. Cheng, L. H.J. Looijenga, B. Janssen, E. F.P.M. Schoenmakers, E. T.H. Yeh, and A. G. van Kessel Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25) Hum. Mol. Genet., July 15, 2005; 14(14): 1955 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Port, H.U. Schmelz, M. Stockinger, C. Sparwasser, P. Albers, T. Pottek, and M. Abend Gene Expression Profiling in Seminoma and Nonseminoma J. Clin. Oncol., January 1, 2005; 23(1): 58 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kemmer, C. L. Corless, J. A. Fletcher, L. McGreevey, A. Haley, D. Griffith, O. W. Cummings, C. Wait, A. Town, and M. C. Heinrich KIT Mutations Are Common in Testicular Seminomas Am. J. Pathol., January 1, 2004; 164(1): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Kernek, T. M. Ulbright, S. Zhang, S. D. Billings, O. W. Cummings, J. D. Henley, H. Michael, M. Brunelli, G. Martignoni, R. S. Foster, et al. Identical Allelic Losses in Mature Teratoma and Other Histologic Components of Malignant Mixed Germ Cell Tumors of the Testis Am. J. Pathol., December 1, 2003; 163(6): 2477 - 2484. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. M. Hopkins, X. Wang, A. Berlin, H. Hang, H. M. Thaker, and H. B. Lieberman Expression of Mammalian Paralogues of HRAD9 and Mrad9 Checkpoint Control Genes in Normal and Cancerous Testicular Tissue Cancer Res., September 1, 2003; 63(17): 5291 - 5298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kimura, A. Suzuki, Y. Fujita, K. Yomogida, H. Lomeli, N. Asada, M. Ikeuchi, A. Nagy, T. W. Mak, and T. Nakano Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production Development, April 15, 2003; 130(8): 1691 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Higuchi, J. S. Palmer, L. E. Gray Jr., and D. N. R. Veeramachaneni Effects of Dibutyl Phthalate in Male Rabbits following in Utero, Adolescent, or Postpubertal Exposure Toxicol. Sci., April 1, 2003; 72(2): 301 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Skotheim, O. Monni, S. Mousses, S. D. Fossa, O.-P. Kallioniemi, R. A. Lothe, and A. Kallioniemi New Insights into Testicular Germ Cell Tumorigenesis from Gene Expression Profiling Cancer Res., April 1, 2002; 62(8): 2359 - 2364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Kraggerud, P. Aman, R. Holm, A. E. Stenwig, S. D. Fossa, J. M. Nesland, and R. A. Lothe Alterations of the Fragile Histidine Triad Gene, FHIT, and Its Encoded Products Contribute to Testicular Germ Cell Tumorigenesis Cancer Res., January 1, 2002; 62(2): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
